Lophos Pharmaceuticals Corp. Announces Participation in the Benzinga Psychedelics Capital Conference
- Written by Newsfile
Napanee, Ontario--(Newsfile Corp. - April 12, 2022) - Lophos Pharmaceuticals Corp. , a biosciences research and development company, will be participating in the Benzinga Psychedelics Capital Conference, which will take place on April 19 at the Fontainebleau Miami Beach.
Claire Stawnyczy, CEO will be speaking at 01:00 PM ET on April 19th....